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OBJECTIVES: The aim of our study was to evaluate the total atrial conduction time and its relationship to
subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes
mellitus.
METHODS: A total of 132 patients with type 2 diabetes mellitus (mean age 54.5¡9.6 years; 57.6% male) and 80
age- and gender-matched controls were evaluated. The total atrial conduction time was measured by tissue-
Doppler imaging and the carotid intima-media thickness was measured by B-mode ultrasonography.
RESULTS: The total atrial conduction time was significantly longer in the patients with type 2 diabetes mellitus
than in the control group (131.7¡23.6 vs. 113.1¡21.3, p,0.001). The patients with type 2 diabetes mellitus had
significantly increased carotid intima-media thicknesses, neutrophil to lymphocyte ratios and high-sensitivity C-
reactive protein levels than those of the controls. The total atrial conduction time was positively correlated with
the high-sensitivity C-reactive protein level, neutrophil to lymphocyte ratio, carotid intima-media thickness and
left atrial volume index and negatively correlated with the early diastolic velocity (Em), Em/late diastolic velocity
(Am) ratio and global peak left atrial longitudinal strain. A multiple logistic regression analysis demonstrated
that the neutrophil to lymphocyte ratio, carotid intima-media thickness and global peak left atrial longitudinal
strain were independent predictors of the total atrial conduction time.
CONCLUSIONS: We suggest that subclinical atherosclerosis and inflammation may represent a mechanism
related to prolonged total atrial conduction time and that prolonged total atrial conduction time and impaired
left atrial myocardial deformation may be represent early subclinical cardiac involvement in patients with type
2 diabetes mellitus.
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& INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a chronic multisystem
disease associated with a high risk of cardiovascular disease
(1). In clinical practice, atrial fibrillation (AF) is the most
frequently observed cardiac arrhythmia and is related to
increased morbidity and mortality. Diabetes is significantly
correlated with AF in both genders even after adjusting for
age and other risk factors (2). However, the pathological
mechanisms related to the initiation and maintenance of AF in
patients with diabetes mellitus have not been well described.
In patients with T2DM, the carotid intima media thick-
ness (CIMT), which is a well-established marker of
subclinical atherosclerosis, is significantly greater than that
in non-diabetic subjects (3). Subclinical chronic inflamma-
tion is widely known to play a key role in the initiation,
propagation and development of diabetes (4). Both labora-
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tory and epidemiological studies have suggested that
subclinical atherosclerosis and inflammation can play a role
in the development of AF (5-9). However, there are not
sufficient data in the literature regarding the relationship
between AF and subclinical atherosclerosis and inflamma-
tion in diabetic patients.
Electrical and structural atrial remodeling, the shortening
of the atrial refractory period and the inhomogeneous
propagation of sinus impulses are well-known electrophy-
siological characteristics of fibrillation-prone atria. The total
atrial conduction time (TACT), measured via tissue Doppler
imaging (PA-TDI Interval), is a novel echocardiographic
parameter used to identify the presence and the extent of
electrical and structural atrial remodeling (10). Previous
studies have shown that a prolonged TACT is a strong and
independent predictor of new-onset AF (11,12). In this
study, we hypothesized that the relationship between DM
and AF may be mediated by the effect of subclinical
atherosclerosis and inflammation on atrial myocardial
tissue.
High-sensitivity C-reactive protein (hsCRP) is an inflam-
matory biomarker that independently predicts the cardio-
vascular risk (13). The neutrophil to lymphocyte ratio
(NLR), as an indicator of systemic inflammation, is an
emerging marker for both cardiac and non-cardiac disorders
(14-15). The CIMT is a widely accepted marker of subclinical
atherosclerosis (3).
To date, no studies have investigated the effects of
subclinical atherosclerosis and inflammation on the TACT,
which is an early predictor of AF development, in patients
with T2DM. In this study, we aimed to evaluate the effects
of T2DM on the TACT and to investigate the possible
relationship between the TACT and echocardiographic
findings, the CIMT and the NLR and hsCRP levels in
patients with T2DM.
& METHODS
Study population
A total of 132 consecutive type 2 diabetic patients who
were diagnosed at least one year prior and 80 sex- and age-
matched healthy controls were enrolled in this observa-
tional, cross-sectional study. T2DM was diagnosed accord-
ing to the American Diabetes Association criteria (16). Of the
diabetic cases, 48 (36.3%) patients were receiving insulin
and 84 (63.7%) patients were receiving an oral anti-diabetic
treatment. The exclusion criteria for the patients were as
follows: a history of coronary artery disease, left ventricular
(LV) systolic dysfunction, moderate to severe valvular heart
disease, arterial hypertension, AF, pre-excitation syn-
dromes, atrioventricular conduction abnormalities, bundle
branch block, previously implanted cardiac pacemakers,
anti-arrhythmic medicine use, electrolyte imbalance, thyr-
oid diseases, chronic renal or liver diseases, pulmonary
disease, chronic inflammatory disorders, known infectious
disease and a history of a hypoglycemic episode in the past
month. The study protocol was approved by our local ethics
committee and all patients provided their written informed
consent to participate in the study.
Echocardiographic examination
Echocardiography was performed using a GE Vivid S5
system (GE Vingmed Ultrasound AS, Norten, Norway) with
a 2.5-MHz phased-array transducer. All subjects were
imaged in the left lateral decubitus position and underwent
a complete transthoracic echocardiographic examination.
All examinations were made by two experienced cardiolo-
gists blinded to the clinical data of the subjects. During the
echocardiography, a 1-lead electrocardiogram (ECG) was
continuously recorded. The LV size measurements and
diastolic LV filling velocities were conducted in accordance
with the American Society of Echocardiography guidelines
(17). The left ventricular ejection fraction (LVEF) was
calculated using Simpson’s biplane method. The LV mass
was calculated with the Devereux formula (18). The
interventricular septal thickness (IVST), posterior wall
thickness (PWT) and left atrial volumes were also measured.
Both the LV mass and the left atrium (LA) volume were
indexed according to the body surface area. Mitral inflow
was assessed from the apical four-chamber view with
pulsed-wave Doppler by placing a 1-2-mm sample volume
between the tips of the mitral leaflets in diastole. From the
mitral inflow E and A wave velocities, the E-deceleration
time (DT) and E/A velocity ratio were obtained. TDI was
performed in the apical 4-chamber view by placing a 1-2-
mm sample volume at the lateral and septal mitral annulus.
The measurements of the systolic (Sm), early diastolic (Em)
and late diastolic (Am) velocities were obtained and
averaged (19). The Em/Am and E/Em ratios were
calculated. The myocardial performance index (MPI) was
measured as previously defined by Tei (20).
The PA-TDI duration is a novel echocardiographic
parameter that can be used to estimate the TACT. The PA-
TDI interval was defined as the time interval from the
initiation of the P-wave on the surface ECG to the peak of
the A wave on the TDI of the lateral wall of the LA, just
above the mitral annulus (Figure 1) (21).
Two-dimensional echocardiography images for the LA
were obtained from the apical two- and four-chamber
views. All images were stored in a cine loop format from
three consecutive beats during a breath hold with a stable
electrocardiographic recording. The frame rate was set
between 60 and 80 frames per second. Speckle-tracking
analyses were performed offline using commercially avail-
able software (EchoPAC; GE Medical Systems). The
endocardial border was manually defined and tracing was
automatically performed by the software for each view. An
image tracking algorithm automatically divided the LA wall
into 6 segments and the peak LA longitudinal strain (PALS)
values for each apical view were measured by averaging the
values observed in all LA segments (Figure 2). The global
PALS values were the averages of the values obtained for
each apical view (22,23).
Assessment of the carotid intima-media thickness
The CIMT was measured using the Toshiba Diagnostic
Ultrasound System (Aplio MX SSA-780A) with a 7.5-MHz
transducer in patients lying in the supine position. The
technique used was in accordance with the consensus
statement from the American Society of Echocardiography
Carotid Intima-Media Thickness Task Force (24). Briefly, the
CIMT was defined as the distance between the leading edge
of the lumen-intima interface and the media-adventitia
interface on the far wall of the common carotid artery (CCA)
(posterior wall). After examination of the transverse and
longitudinal planes of the carotid arteries, the CIMT was
measured in both arteries approximately 1 cm proximal to
the carotid artery bifurcation in an area free of plaque. At
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least three measurements were performed on both sides and
averaged. Then, the average of the measurements obtained
from both CCAs was taken as the CIMT.
Analysis of blood samples
After fasting overnight for 12 h, venous blood samples
were obtained for all patients from the antecubital space.
Figure 1 - Measurement of the total atrial conduction time (PA-TDI interval). The PA-TDI interval was defined as the time interval
between the onset of the P-wave on the surface ECG and the peak Am wave on the tissue Doppler tracing. ECG: electrocardiogram;
Am: tissue Doppler mitral annular late diastolic velocity.
Figure 2 - Assessment of the peak atrial longitudinal strain by two-dimensional speckle-tracking echocardiography. The dashed curve
represents the average atrial longitudinal strain along the cardiac cycle.
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Total and differential leukocyte counts were measured as
part of the automated complete blood count using a Coulter
LH 780 Hematology Analyzer (Beckman Coulter Inc.,
Miami, FL, USA). HsCRP and other biochemical parameters
were measured by standard laboratory procedures. The
NLR was obtained by dividing the total neutrophil count by
the total lymphocyte count.
Statistical analysis
Continuous variables are presented as the mean +
standard deviation or the median (interquartile range)
values and categorical variables are presented as a
percentage. The one-sample Kolmogorov-Smirnov test was
used to evaluate whether the distribution of continuous
variables was normal. Continuous variables between 2
groups were compared with Student’s t test or the Mann-
Whitney U test. Categorical variables were compared
appropriately with the chi-square test or Fisher’s exact test.
The correlations between variables were tested by Pearson’s
correlation tests for normally distributed variables and with
Spearman’s correlation tests for non-normally distributed
variables. The TACT was categorized into two groups, with
the median as the cut-off point. To determine the indepen-
dent predictors of supramedian TACT, parameters that
were found to have significance (p,0.05) in the univariate
analysis were evaluated by stepwise forward logistic
regression analysis; 95% confidence intervals (CIs) and
odds ratios (ORs) were presented together. Receiver–
operating characteristic (ROC) analysis was used to com-
pare the performance and prognostic power of the NLR,
CIMT and PALS for supramedian TACT. The predictive
validities were quantified as the area under the ROC curves
(c statistics) and the comparisons of c statistics were
performed using the MedCalc statistical software (version
11.3.8.0, Mariakerke, Belgium). To assess the reproducibility
of the CIMT, TACT and global PALS measurements, 20
patients were randomly selected. For the interobserver and
intraobserver variability, Bland-Altman analysis and intra-
class correlation coefficient were used, respectively. A 2-
sided p value ,0.05 was considered significant in all
analyses. Data were analyzed using SPSS version 15.0
(SPSS Inc., Chicago, Illinois).
& RESULTS
The study population comprised 132 T2DM patients
(mean age 54.5¡9.6 years; 57.6% male) and 80 controls
(mean age 53.2¡9.0 years; 62.5% male). The demographic
findings and laboratory values of the study groups are
presented in Table 1. The age, sex, body mass index,
smoking status, systolic and diastolic blood pressures and
heart rate were similar between the 2 groups (p.0.05). In
patients with T2DM, the mean HbA1c level was 8.4%¡2.7%
and the mean disease duration was 83.4¡52.5 months. The
patients with T2DM had a significantly increased CIMT
compared with the controls (0.80¡0.25 vs. 0.66¡0.13 mm,
p,0.001). When the laboratory findings were compared,
T2DM patients had significantly higher NLRs and hsCRP
levels (3.7¡1.4 vs. 2.5¡1.2, p,0.001; 1.0¡0.4 vs. 0.8¡0.4,
p= 0.003, respectively).
The LV echocardiographic findings in the subjects are
shown in Table 2. The E/A ratio was significantly decreased
in the patients with T2DM. The tissue Doppler Am was
higher in the diabetic group; consequently, the average Em/
Am ratio was significantly decreased in this group. The left
atrial volume index (LAVI) was significantly increased in
the diabetic patients (32.7¡6.4 vs. 23.6¡5.6, p,0.001).
Global PALS was found to be significantly decreased in
the patients with T2DM compared with the control group
(24.5¡6.6 vs. 33.4¡8.2, p,0.001). TACT was significantly
longer in the patients with T2DM than in healthy subjects
(131.7¡23.6 vs. 113.1¡21.3, p,0.001). The LVEF, IVST,
PWT, LV mass index, Mitral E and A velocities, DT, Sm and
Em values, E/Em ratio, and MPI were similar in both
groups (p.0.05).
The TACT was positively correlated with hsCRP levels
(r = 0.197, p= 0.024), the NLR (r = 0.311, p,0.001), the CIMT
(r = 0.364, p,0.001) and the LAVI (r = 0.184, p= 0.035) and
negatively correlated with the Em value (r = -0.296,
Table 1 - Clinical and laboratory characteristics of the
study population.
Patients with DM Controls
(n = 132) (n = 80) p
Age, years 54.5¡9.6 53.2¡9.0 0.315
Gender, Male (%) 76(57.6%) 50(62.5%) 0.479
BMI (kg/m2) 23.5¡5.8 22.1¡6.1 0.116
Smoking (%) 50(37.9%) 27(33.8%) 0.545
SBP (mmHg) 116.8¡12.9 114.8¡14.6 0.315
DBP (mmHg) 68.6¡8.5 67.9¡8.7 0.608
Heart rate (beats/min) 73.2¡10.2 74.7¡11.6 0.339
Disease duration (mo) 83.4¡52.5 - -
NLR 3.7¡1.4 2.5¡1.2 ,0.001
HsCRP (mg/L) 1.0¡0.4 0.8¡0.4 0.003
CIMT 0.80¡0.25 0.66¡0.13 ,0.001
BMI: body mass index; SDP: systolic blood pressure; DBP: diastolic blood
pressure; NLR: neutrophil to lymphocyte ratio; hsCRP: high-sensitivity C-
reactive protein; CIMT: carotid intima-media thickness.
Table 2 - Echocardiographic characteristics of the study
population.
Patients with DM Controls
(n = 132) (n = 80) p
LVEF (%) 62.3(59.0-65.3) 63.4(60.9-65.2) 0.130
IVST (mm) 10.0(9.2-10.4) 9.7(9.0-10.3) 0.146
LVPWT (mm) 8.3(7.4-9.1) 8.2(7.4-9.2) 0.811
LV mass index (g/m2) 80.2¡16.2 77.1¡15.1 0.154
Mitral E velocity (m/sn) 0.92(0.70-0.93) 0.82(0.72-1.0) 0.637
Mitral A velocity (m/sn) 0.65(0.53-0.67) 0.57(0.53-0.70) 0.055
E/A ratio 1.33(0.76-1.65) 1.44(0.99-1.78) 0.028
DT (ms) 173.1¡28.8 172.2¡24.3 0.816
Sm (cm/sn) 7.9(7.1-9.2) 8.1(7.9-8.5) 0.051
Em (cm/sn) 9.6(8.2-11.5) 9.9(8.5-11.7) 0.299
Am (cm/sn) 7.3¡0.8 7.0¡0.9 0.014
Em/Am ratio 1.3¡0.3 1.4¡0.3 0.012
E/Em ratio 8.9¡2.8 8.6¡2.5 0.380
MPI 45.5¡7.3 44.3¡7.1 0.264
LAVI (ml/m2) 32.7¡6.4 23.6¡5.6 ,0.001
PALS (%) 24.5¡6.6 33.4¡8.2 ,0.001
TACT (ms) 131.7¡ 23.6 113.1¡21.3 ,0.001
LVEF: left ventricular ejection fraction; IVST: interventricular septum
thickness, LVPWT: left ventricular posterior wall thickness; LV: left
ventricular; DT: deceleration time; Sm: tissue Doppler mitral annular
systolic velocity; Em: tissue Doppler mitral annular early diastolic velocity;
Am: tissue Doppler mitral annular late diastolic velocity; MPI: myocardial
performance index; LAVI: left atrial volume index; PALS: peak atrial
longitudinal strain; TACT: total atrial conduction time.
Total atrial conduction time and type 2 diabetes mellitus
Bakirci EM et al.
CLINICS 2015;70(2):73-80
76
p= 0.001), the Em/Am ratio (r = -0.195, p= 0.025) and global
PALS (r = -0.188, p= 0.031) (Table 3). TACT was categorized
into two groups, with the median as the cutpoint (,or
$125.5). Variables showing significance values of p,0.05 in
the univariate analysis (Table 4) between the inframedian
and supramedian TACT groups were included in the
multiple logistic regression model. There was multicolli-
nearity between the Em value and Em/Am ratio; thus, Em
was not included in the model. Accordingly, the NLR (OR:
1.78, 95% CI: 1.28-2.46; p,0.001), CIMT (OR: 7.99, 95% CI:
1.46-33.04; p= 0.016), and PALS (OR: 0.93, 95% CI: 0.87-0.99;
p= 0.035) were found to be independent predictors of the
TACT (Table 5). The cutoff value for supramedian TACT of
the NLR was 4.0, with a sensitivity of 74.2% and a specificity
of 72.7% (AUC, 0.708; 95% CI, 0.622-0.784; p,0.001), of
CIMT was 0.81 mm, with a sensitivity of 75.8% and a
specificity of 72.7% (AUC, 0.684; 95% CI, 0.597-0.762;
p,0.001) and of PALS was 19.8%, with a sensitivity of
41% and a specificity of 83.3% (AUC, 0.602; 95% CI, 0.514-
0.686; p= 0.038) in the ROC curve analysis (Figure 3).
However, the AUC comparison of these parameters did
not reach statistical significance (p.0.05). The results of the
inter- and intraobserver agreement analyses for TACT,
PALS and CIMT are shown in Table 6.
& DISCUSSION
The present study demonstrated that the TACT, mea-
sured with TDI, was increased and that LA myocardial
deformation, assessed by two-dimensional strain imaging,
was impaired in patients with T2DM. Furthermore, in this
study, we also found that the NLR, CIMT and global PALS
were independent predictors of the TACT in these patients.
Epidemiological studies have shown that the rate of AF
development in diabetic subjects is higher than in normal
subjects (25). A possible explanation for why diabetes
mellitus causes predisposition to AF may involve LV
hypertrophy, myocardial ischemia or fibrosis, left atrial
remodeling, altered autonomic tone and inflammation
(9,26,27). Additionally, the clinical hypoglycemic episodes
in diabetic patients cause sympathetic activation, QT
interval prolongation and cardiac repolarization. These
changes may increase the risk of AF (28). However, the
underlying mechanisms are still not clearly elucidated. The
previous studies have demonstrated that the TACT,
measured via the PA-TDI interval, could be used to predict
the development of AF (29). Acar G et al. (30) reported that
intra- and interatrial electromechanical coupling and atrial
electromechanical delay, measured with TDI, were higher in
patients with type 1 DM than in control subjects. In a recent
experimental study, Fu H et al. (31) detected that the
interatrial conduction time was prolonged in diabetic
rabbits. In line with the results of these studies, in our
study, we found that the TACT was significantly longer in
patients with T2DM than in control subjects. In previous
studies, chronic hyperglycemia was reported to cause
prolongation of the interatrial conduction time by aggravat-
ing atrial fibrosis (32). However, the exact mechanism of
TACT prolongation in diabetic patients remains unknown.
In a recent retrospective study, Chen LY et al. (33)
reported that increased CIMT and arterial stiffness are
associated with lone AF. In the population-based Rotterdam
Study, Heeringa J et al. (7) reported that subclinical
atherosclerosis, determined based on the CIMT, predicted
new-onset AF in patients without overt coronary artery
disease. In another population-based cohort study,
Adamsson ES et al. (34) found that the CIMT is associated
with the incidence of AF hospitalizations among middle-
aged subjects. In contrast, the Cardiovascular Health Study
(CHS) found no association between the CIMT and the AF
incidence (35). Although these studies are population based,
there are important differences in both the age distributions
Table 3 - Bivariate correlation results between the total
atrial conduction time and other parameters in diabetic
patients.
Variables r p
HsCRP 0.197 0.024
NLR 0.311 ,0.001
CIMT 0.364 ,0.001
LAVI 0.184 0.035
Em -0.296 0.001
Em/Am -0.195 0.025
PALS -0.188 0.031
HsCRP: high-sensitivity C-reactive protein; NLR: neutrophil to lymphocyte
ratio; CIMT: carotid intima-media thickness; LAVI: left atrial volume index;
Em: tissue Doppler mitral annular early diastolic velocity; Am: tissue
Doppler mitral annular late diastolic velocity; PALS: peak atrial
longitudinal strain.
Table 4 - Comparison of clinical and echocardiographic
variables between the inframedian and supramedian
total atrial conduction times.
TACT ,125.5 TACT $125.5
n=66 n=66 p
Age, years 52.8¡9.9 56.2¡8.9 0.048
HsCRP 0.9¡0.4 1.1¡0.4 0.043
NLR 3.2¡1.2 4.2¡1.4 ,0.001
CIMT 0.72¡0.22 0.88¡0.26 ,0.001
Em 10.4(8.7-12.0) 8.8(7.8-11.0) 0.001
Em/Am 1.4¡0.2 1.2¡0.3 0.034
LAVI 31.5¡5.8 33.9¡6.8 0.035
PALS 25.7¡6.6 23.2¡6.4 0.031
HsCRP: high-sensitivity C-reactive protein; NLR: neutrophil to lymphocyte
ratio; CIMT: carotid intima-media thickness; Em: tissue Doppler mitral
annular early diastolic velocity; Am: tissue Doppler mitral annular late
diastolic velocity; LAVI: left atrial volume index; PALS: peak atrial
longitudinal strain.
Table 5 - Independent predictors of the total atrial
conduction time in the multiple logistic regression
analysis.
Variables Multiple OR (95% CI) p
Age 1.04(0.99-1.09) 0.068
HsCRP 2.60(0.99-6.84) 0.052
NLR 1.78(1.28-2.46) ,0.001
CIMT 7.99(1.46-33.58) 0.016
LAVI 1.03(0.97-1.11) 0.326
Em/Am 0.26(0.06-1.13) 0.073
PALS 0.93(0.87-0.99) 0.035
HsCRP: high-sensitivity C-reactive protein; NLR: neutrophil to lymphocyte
ratio; CIMT: carotid intima-media thickness; LAVI: left atrial volume index;
Em: tissue Doppler mitral annular early diastolic velocity; Am: tissue
Doppler mitral annular late diastolic velocity; PALS: peak atrial
longitudinal strain.
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and the case report methods between the studies that might
explain the different results. Subclinical atherosclerosis may
lead to the development of fibrosis and microscopic scarring
with consecutive remodeling of atrial tissue over time by
decreasing the blood flow to the sinus node and atrial tissue
(36). Atrial remodeling may account for the atrial conduc-
tion disturbances and the dispersion of the atrial refractory
period, thereby facilitating reentry processes and the onset
of atrial fibrillation (37). The TACT is a novel echocardio-
graphic parameter used to assess the extent of atrial
remodeling. In our study, we detected a weak but
statistically significant positive correlation (r = 0.364,
p,0.001) between the CIMT and the TACT, and the CIMT
strongly and independently predicted the TACT in diabetic
patients (OR: 7.99). Additionally, our study showed that a
CIMT$0.81 mm predicted the presence of a longer TACT,
with a sensitivity of 75.8% and a specificity of 72.7%.
Generally, the relationship between AF and inflammation
has been well established (38). Histological studies have
demonstrated evidence of inflammatory infiltrates and
oxidative damage within the atrial tissue in patients with
AF compared with control subjects (5). Liu T et al. (9)
suggested that inflammation was one of the mechanisms
responsible for AF in diabetic patients. Inflammatory stimuli
provoke fibroblast proliferation, migration and transforma-
tion into myofibroblasts and lead to atrial remodeling
characterized by the shortening of the atrial refractory period
(38). In studies investigating the AF-inflammation relation-
ship, the most frequently studied inflammatory markers
were CRP, hsCRP and interleukin (IL)-6 (5). In a few studies,
the development of AF after cardiac surgery and the
recurrence of AF after cryoballoon-based AF ablation were
demonstrated to correlate with the NLR (39). Acar G et al.
(40) have shown that atrial electromechanical delay is closely
associated with the plasma level of CRP in patients with
familial Mediterranean fever.
In our study, we detected a weak but statistically
significant positive correlation (r = 0.311, p,0.001 and
r = 0.197, p= 0.024, respectively) between the TACT, the
NLR and hsCRP levels; in addition, the NLR independently
predicted a longer TACT in diabetic patients (OR: 1.78).
Furthermore, we showed that an NLR$4.0 mm predicted
the presence of a longer TACT, with a sensitivity of 74.2 and
a specificity of 72.7.
In our study, the patients with T2DM had an increased
LAVI and decreased E/A and Em/Am ratios compared
with the normal volunteers. These results are consistent
with prior studies in asymptomatic, normotensive type 1
and 2 diabetic patients (41). An increase in the LA volume
might change the atrial fibrillar geometry, which in turn
may contribute to TACT prolongation. We detected statis-
tically significant but weak correlations between the TACT
and the LAVI and the Em/Am ratio. However, it was
demonstrated in our study that the LAVI and the Em/Am
ratio were not strong parameters for predicting the longer
TACT (OR: 1.03 and OR: 0.26, respectively). In previous
studies, impaired LA deformation, assessed by the global
PALS, was shown to correlate with atrial fibrosis and
remodeling and was related to paroxysmal AF (22). In this
study, we revealed that the global PALS decreased and was
weakly but significantly correlated with the TACT in
patients with T2DM. Among the echocardiographic para-
meters, only the global PALS independently predicted
TACT (OR: 0.93). In addition, our study demonstrated that
a PALS,19.8% predicted the presence of a longer TACT,
with a sensitivity of 41% and a specificity of 83.3%.
In our study, the weak correlations detected between the
TACT, the CIMT, the NLR, the hsCRP level and the
echocardiographical parameters may have stemmed from
the limited number of patients included in our study and
relatively short disease duration. We only investigated the
effects of subclinical atherosclerosis and inflammation on the
TACT. However, other causes, such as cardiac autonomic
neuropathy, renin-angiotensin aldosterone system activation,
sympathetic overactivity, neural remodeling, the left atrial
myocardial injury and fibrotic changes due to sustained
hyperglycemia, all of which may cause an increased AF
frequency and left atrial functional deterioration, could
contribute to the prolongation of the TACT (42). The possible
stronger relationships between the TACT and these factors
may have led to the weak correlations observed between the
TACT and the CIMT, NLR and hsCRP levels.
Limitations
The most important limitation is the cross-sectional
design of the study; the patients were not prospectively
Figure 3 - Comparison ROC curves for the CIMT, NLR and PALS in
the prediction of a longer TACT. ROC: receiver operating
characteristic; CIMT: carotid intima-media thickness; NLR: neu-
trophil to lymphocyte ratio; PALS: peak atrial longitudinal strain;
TACT: total atrial conduction time.
Table 6 - The Results of Inter- and Intraobserver Agreement Analyses.
Variables 95% Intraclass Correlation Bland-Altman
Coefficient (95% CI) Mean Difference Limits of Agreement
TACT 0.98 (0.97-0.99) -0.15 0.57, -0.87
PALS 0.96(0.90-0.98) -1.8 2.8, -6.4
CIMT 0.97(0.93-0.98) - -
TACT: total atrial conduction time; PALS: peak atrial longitudinal strain; CIMT: carotid intima-media thickness.
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followed-up in terms of arrhythmic episodes. Thus, we do
not know whether TACT prolongation, subclinical athero-
sclerosis and inflammation, and impaired LA deformation
predict AF in patients with T2DM. For this reason, the
current findings need to be validated by long-term follow-
up and in larger prospective studies. In our study, the TACT
was not investigated by invasive electrophysiological
techniques. Although we did not evaluate the patients
who described a hypoglycemic episode within the past
month, probable unreported hypoglycemic episodes occur-
ring in the diabetic patients might have affected our study
results. Another limitation was the use of non-invasive
imaging techniques to exclude coronary artery disease in
the study population. Coronary angiography was not
performed in our study population on ethical grounds.
In the current study, we found that the TACT predicting
AF development was prolonged and that LA myocardial
deformation was impaired in patients with T2DM. Our study
also indicated that subclinical atherosclerosis, inflammation
and the global PALS were independently related to TACT.
On the basis of these findings, we suggest that subclinical
atherosclerosis and inflammation may be a mechanism
related to TACT prolongation and prolonged TACT and
impaired LA myocardial deformation may represent an early
form of subclinical cardiac involvement in patients with
T2DM and without clinical evidence of cardiovascular
disease.
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